Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emergence and transmissibility of neuraminidase inhibitor resistance in pandemic influenza
2009-012876-29Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oseltamivir and zanamivir in influenza (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoints: Frequency of phenotypic resistance to neuraminidase inhibitors and Frequency of genotypic resistance to neuraminidase inhibitors. Started May 2009; status: completed.
02
Drugs
oseltamivirzanamivir
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-012876-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012876-29.